Burning Rock Biotech Ltd - Company Profile

Powered by

All the data and insights you need on Burning Rock Biotech Ltd in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Burning Rock Biotech Ltd Strategy Report

  • Understand Burning Rock Biotech Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Burning Rock Biotech Ltd: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Burning Rock Biotech Ltd (BRB) is a biotechnology company. It is involved in providing individualized cancer treatment guidance for the patients. The company offers core products such as OncoCompass IO, OncoScreen IO, OncoCompass Target, OncoScreen ParpMatch, Lung Core, Colon Core, Prostate Core, Onco Screen Risk, Lung Core, Colon Core, Prostate Core, Breast Core, Thyro Core, Lymph Plasma and BRCA testing. It focuses on NGS (Next-Generation Sequencing) diagnostics solutions for providing precision medicine in oncology. BRB provides cancer therapy selection tests to a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer and bladder cancer. It also provides multi-dimensional genomic data, multimodal central lab testing, integrated companion diagnostic development and commercialization. The company mainly conducts its business in the China market. BRB is headquartered in Guangzhou, Guangdong, China.

 Gain a 360-degree view of Burning Rock Biotech Ltd and make more informed decisions for your business Gain a 360-degree view of Burning Rock Biotech Ltd and make more informed decisions for your business Find out more
Headquarters China
Address No. 5 Xingdao Ring Road North, , International Bio Island, Guangzhou, Guangdong, 510005
Website www.brbiotech.com
Telephone 86 18 501641666
No of Employees 1,138
Industry Medical Equipment
Ticker Symbol & Exchange BNR (NASD)
Revenue (2022) $76.0M -4.6% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 32.7% (2022 vs 2021)
Market Cap* $823.8M
Net Profit Margin (2022) XYZ 29.5% (2022 vs 2021)
* As of and is in US$
View Burning Rock Biotech Ltd financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Burning Rock Biotech Ltd premium industry data and analytics

11+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

4

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Products and Services

Products
OncoCompass IO
OncoScreen IO
OncoCompass Target
XYZ
XYZ
XYZ
Understand Burning Rock Biotech Ltd portfolio and identify potential areas for collaboration Understand Burning Rock Biotech Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In October, the company entered into an agreement with Boehringer Ingelheim to provide Chinese patients with safer, more efficient, and more precise treatment options and diagnostic methods, thereby promoting innovation and development in cancer treatment.
2021 Contracts/Agreements In November, the company entered into a partnership with IMPACT Therapeutics to provide testing services in connection with IMPACT Therapeutics’ development of its ATR inhibitor IMP9064.
2021 Contracts/Agreements In August, the company entered into a partnership with IMPACT Therapeutics for companion diagnostics development.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Burning Rock Biotech Ltd BGI Genomics Co Ltd Novogene Co Ltd AmoyDx (Canada) Ltd Creative Biosciences (Guangzhou) Co Ltd
Headquarters China China China Canada China
City Guangzhou Shenzhen Beijing Vancouver Guangzhou
State/Province Guangdong Guangdong Beijing British Columbia Guangdong
No. of Employees 1,138 3,752 2,144 - -
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Yusheng Han Chairman; Founder; Director; Chief Executive Officer Executive Board 2013 44
Leo Li Director; Chief Financial Officer Executive Board 2019 38
Zhihong (Joe) Zhang Chief Technology Officer; Director Executive Board 2023 -
Min-Jui Richard Shen Director Non Executive Board 2020 58
Feng Deng Director Non Executive Board 2016 59
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Burning Rock Biotech Ltd key executives to enhance your sales strategy Gain insight into Burning Rock Biotech Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer